Pr Ariel Masetto, M.D.Professeur adjoint |
| Service de rhumatologie Département de médecine Faculté de médecine et des sciences de la santé Université de Sherbrooke 3001, 12e Avenue Nord Sherbrooke (Québec) J1H 5N4 Téléphone : 819 564-5261 Télécopieur : 819 564-5265 Courriel : Ariel.Masetto@USherbrooke.ca Site Internet |
University of São Paulo, Brazil.
Chercheur principal : Boire G
Co-chercheurs : Cossette P, Daniel C, de Brum-Fernandes A, Dobkin PL, Urgan L, Ménard HA, Arsenault G, Liang P, Bruns A., Masetto AOrganisme subventionnaire :
IRSC
(2011-03/2016)
Chercheur principal : Masetto A
Organisme subventionnaire :
Canadian Research and Education (CARE) Arthritis
(2013-....)
Chercheur principal : Masetto A
Organisme subventionnaire :
Hôpital général juif
(2012-....)
Chercheur principal : Masetto A
Co-chercheurs : St-Onge C et al.Organisme subventionnaire :
Société canadienne de rhumatologie
(2012-....)
Chercheur principal : Masetto A
Organisme subventionnaire :
Janssen-Ortho inc.
Chercheur principal : Masetto A
Organisme commanditaire :
AbbVie Corp.
Chercheur principal : Masetto A
Organisme commanditaire :
UCB Canada inc.
Chercheur principal : Masetto A
Organisme commanditaire :
Laboratoires Abbott ltée
Chercheur principal : Masetto A
Organisme commanditaire :
Actelion Pharmaceuticals
The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review.
Muangchan C; Canadian Scleroderma Research Group (Masetto A), Baron M, Pope J.
J Rheumatol. 2013 Sep;40(9):1545-56. doi: 10.3899/jrheum.121380. Epub 2013 Jul 15. PMID:23858045
Prevention of rheumatoid arthritis: the very first steps.
Masetto A, Beaulieu MC, Boire G.
J Rheumatol. 2013 Jun;40(6):752-4. doi: 10.3899/jrheum.130326. No abstract available. PMID:23728185
Systemic sclerosis in Canada's North American Native population: assessment of clinical and serological manifestations.
Bacher A, Mittoo S, Hudson M, Tatibouet S; Canadian Scleroderma Research Group, Baron M.
J Rheumatol. 2013 Jul;40(7):1121-6. doi: 10.3899/jrheum.121212. Epub 2013 May 15. PMID: 23678158
Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis.
Zhang XJ, Bonner A, Hudson M; Canadian Scleroderma Research Group (Masetto A), Baron M, Pope J.
J Rheumatol. 2013 Jun;40(6):850-8. doi: 10.3899/jrheum.120705. Epub 2013 Apr 1. PMID:23547215
Low socioeconomic status (measured by education) and outcomes in systemic sclerosis: data from the Canadian Scleroderma Research Group.
Mansour S, Bonner A, Muangchan C, Hudson M, Baron M, Pope JE; Canadian Scleroderma Research Group (Masetto A).
J Rheumatol. 2013 Apr;40(4):447-54. doi: 10.3899/jrheum.120570. Epub 2013 Feb 15. PMID: 23418377
Cross-language measurement equivalence of the Center for Epidemiologic Studies Depression (CES-D) scale in systemic sclerosis: a comparison of Canadian and Dutch patients.
Kwakkenbos L, Arthurs E, van den Hoogen FH, Hudson M, van Lankveld WG, Baron M, van den Ende CH, Thombs BD; Canadian Scleroderma Research Group (Masetto A).
PLoS One. 2013;8(1):e53923. doi: 10.1371/journal.pone.0053923. Epub 2013 Jan 11. PMID: 23326538
High prevalence of occult left heart disease in scleroderma-pulmonary hypertension.
Fox BD, Shimony A, Langleben D, Hirsch A, Rudski L, Schlesinger R, Eisenberg MJ, Joyal D, Hudson M, Boutet K, Serban A, Masetto A, Baron M.
Eur Respir J. 2013 Oct;42(4):1083-91. doi: 10.1183/09031936.00091212. Epub 2012 Dec 20. PMID:23258775
Consensus statements for the use of administrative health data in rheumatic disease research and surveillance.Bernatsky S, Lix L, O'Donnell S, Lacaille D; CANRAD Network (Masetto A).
J Rheumatol. 2013 Jan;40(1):66-73. doi: 10.3899/jrheum.120835. Epub 2012 Nov 1. PMID: 23118109
Longitudinal study of renal function in systemic sclerosis.
Caron M, Hudson M, Baron M, Nessim S, Steele R; Canadian Scleroderma Research Group (Masetto A).J Rheumatol. 2012 Sep;39(9):1829-34. doi: 10.3899/jrheum.111417. Epub 2012 Aug 1. PMID: 22859351
Best practices in scleroderma: an analysis of practice variability in SSc centres within the Canadian Scleroderma Research Group (CSRG).
Harding S, Khimdas S, Bonner A, Baron M, Pope J; Canadian Scleroderma Research Group (Masetto A).Clin Exp Rheumatol. 2012 Mar-Apr;30(2 Suppl 71):S38-43. Epub 2012 May 29. PMID: 22691207
Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
Muangchan C, Harding S, Khimdas S, Bonner A; Canadian Scleroderma Research group (Masetto A), Baron M, Pope J.
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1405-14. doi: 10.1002/acr.21716. PMID: 22556030
Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis.Hudson M, Mahler M, Pope J, You D, Tatibouet S, Steele R, Baron M; Investigators of the Canadian Scleroderma Research Group (Masetto A), Fritzler M.
J Rheumatol. 2012 Apr;39(4):787-94. doi: 10.3899/rheum.111133. PMID: 22467948
Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts.
Walker KM, Pope J; participating members of the Scleroderma Clinical Trials Consortium (SCTC); Canadian Scleroderma Research Group (CSRG) (Masetto A). Semin Arthritis Rheum. 2012 Aug;42(1):42-55. doi: 10.1016/j.semarthrit. 2012.01.003. Epub 2012 Mar 29. PMID: 22464314
Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis.
Hudson M, Pope J, Mahler M, Tatibouet S, Steele R, Baron M; Canadian Scleroderma Research Group (CSRG) (Masetto A), Fritzler MJ.
Arthritis Res Ther. 2012 Mar 6;14(2):R50. doi: 10.1186/ar3763.PMID: 22394602
Agreement with guidelines from a large database for management of systemic sclerosis: results from the Canadian Scleroderma Research Group.
Pope J, Harding S, Khimdas S, Bonner A; Canadian Scleroderma Research Group (Masetto A), Baron M.
J Rheumatol. 2012 Mar;39(3):524-31. doi: 10.3899/jrheum.110121. Epub 2012 Jan 15. PMID: 22247347
Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis.
Steele R, Hudson M, Lo E, Baron M; Canadian Scleroderma Research Group (Masetto A).
Arthritis Care Res (Hoboken). 2012 Apr;64(4):519-24. doi: 10.1002/acr.21583. PMID: 22213733
Rates and correlates of sexual activity and impairment among women with systemic sclerosis.
Levis B, Hudson M, Knafo R, Baron M, Nielson WR, Hill M, Thombs BD; Canadian Scleroderma Research Group (CSRG) (Masetto A).
Arthritis Care Res (Hoboken). 2012 Mar;64(3):340-50. doi: 10.1002/acr.20696. PMID: 22076868
Measuring pain in systemic sclerosis: comparison of the short-form McGill Pain Questionnaire versus a single-item measure of pain.
El-Baalbaki G, Lober J, Hudson M, Baron M, Thombs BD;Canadian Scleroderma Research Group.
J Rheumatol. 2011 Dec;38(12):2581-7. Epub 2011 Oct 1. PMID: 21965643
Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
Mahler M, You D, Baron M, Taillefer SS, Hudson M; Canadian Scleroderma Research Group(CSRG), Fritzler MJ.
Clin Chim Acta. 2011 Oct 9;412(21-22):1937-43. Epub 2011 Jul 5. PMID: 21756890
Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis.
Sharif R, Fritzler MJ, Mayes MD, Gonzalez EB, McNearney TA, Draeger H, Baron M; Canadian Scleroderma Research Group, Furst DE, Khanna DK, del Junco DJ, Molitor JA, Schiopu E, Phillips K, Seibold JR, Silver RM, Simms RW; GENISOS Study Group, Perry M, Rojo C, Charles J, Zhou X, Agarwal SK, Reveille JD, Assassi S, Arnett FC.
J Rheumatol. 2011 Aug;38(8):1622-30. Epub 2011 May 15. PMID: 21572159
Expert agreement on EULAR/EUSTAR recommendations for the management of systemic sclerosis.
Walker KM, Pope J; Scleroderma Clinical Trials Consortium; Canadian Scleroderma Research Group.
J Rheumatol. 2011 Jul;38(7):1326-8. Epub 2011 Apr 1. PMID: 21459952
Modeling smoking in systemic sclerosis: a comparison of different statistical approaches.
Hudson M, Lo E, Baron M, Steele R; Canadian Scleroderma Research Group.
Arthritis Care Res (Hoboken). 2011 Apr;63(4):570-8. doi: 10.1002/acr.20416. PMID: 21452268
Observational data to study medication outcomes in systemic sclerosis.
Hudson M, Baron M; Canadian Scleroderma Research Group (CSRG), Steele R.
J Rheumatol. 2011 Mar;38(3):575-7. No abstract available. PMID: 21362793
Reliability of widefield capillary microscopy to measure nailfold capillary density in systemic sclerosis.
Hudson M, Masetto A, Steele R, Arthurs E, Baron M; Canadian Scleroderma Research Group.
Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 62):S36-41. Epub 2010 Nov 3. PMID: 21050543
Association of pruritus with quality of life and disability in systemic sclerosis.
El-Baalbaki G, Razykov I, Hudson M, Bassel M, Baron M, Thombs BD; Canadian Scleroderma Research Group.
Arthritis Care Res (Hoboken). 2010 Oct;62(10):1489-95. PMID: 20506531
The association between disease activity and duration in systemic sclerosis.
Walker JG, Steele RJ, Schnitzer M, Taillefer S, Baron M; Canadian Scleroderma Research Group, Hudson M.
J Rheumatol. 2010 Nov;37(11):2299-306. Epub 2010 Sep 1. PMID: 20810506
Discordance between patient and physician assessments of disease severity in systemic sclerosis.
Hudson M, Impens A, Baron M, Seibold JR, Thombs BD, Walker JG; Canadian Scleroderma Research Group, Steele R.
J Rheumatol. 2010 Nov;37(11):2307-12. Epub 2010 Sep 15. PMID: 20843907
Systemic sclerosis: establishing diagnostic criteria.
Hudson M, Fritzler MJ, Baron M; Canadian Scleroderma Research Group (CSRG).
Medicine (Baltimore). 2010 May;89(3):159-65. PMID: 20453602
Comparison of the PHQ-9 and CES-D depression scales in systemic sclerosis: internal consistency reliability, convergent validity and clinical correlates.
Milette K, Hudson M, Baron M, Thombs BD; Canadian Scleroderma Research Group.
Rheumatology (Oxford). 2010 Apr;49(4):789-96. Epub 2010 Jan 25. PMID: 20100794
Is serum albumin a marker of malnutrition in chronic disease? The scleroderma paradigm.
Baron M, Hudson M, Steele R; Canadian Scleroderma Research Group (CSRG).
J Am Coll Nutr. 2010 Apr;29(2):144-51. PMID: 20679150
Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis.
Schieir O, Thombs BD, Hudson M, Boivin JF, Steele R, Bernatsky S, Hanley J, Baron M; Canadian Scleroderma Research Group.
Arthritis Care Res (Hoboken). 2010 Mar;62(3):409-17. PMID: 20391488
The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma.
Sekhon S, Pope J; Canadian Scleroderma Research Group, Baron M.
J Rheumatol. 2010 Mar;37(3):591-8. Epub 2010 Jan 15. PMID: 20080913
Prevalence and clinical correlates of pruritus in patients with systemic sclerosis.
Razykov I, Thombs BD, Hudson M, Bassel M, Baron M; Canadian Scleroderma Research Group.
Arthritis Rheum. 2009 Dec 15;61(12):1765-70.PMID: 19950328
Malnutrition is common in systemic sclerosis: results from the canadian scleroderma research group database.
Baron M, Hudson M, Steele R; Canadian Scleroderma Research Group.
J Rheumatol. 2009 Dec;36(12):2737-43. Epub 2009 Oct 15. PMID: 19833750
Work disability in systemic sclerosis.
Hudson M, Steele R, Lu Y, Thombs BD; Canadian Scleroderma Research Group, Baron M.
J Rheumatol. 2009 Nov;36(11):2481-6. Epub 2009 Oct 1. PMID: 19797513
Health-related quality of life in systemic sclerosis: a systematic review.
Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M; Canadian Scleroderma Research Group.
Arthritis Rheum. 2009 Aug 15;61(8):1112-20. Review. PMID: 19644906
Validity of self-reported comorbidities in systemic sclerosis.
Hudson M, Sharma A, Bernstein J; CANADIAN SCLERODERMA RESEARCH GROUP, Baron M.
J Rheumatol. 2009 Jul;36(7):1477-80. Epub 2009 Jun 1. PMID: 19487272
Clinical correlates of self-reported physical health status in systemic sclerosis.
Hudson M, Steele R, Lu Y, Thombs BD, Panopalis P, Baron M; Canadian Scleroderma Research Group.
J Rheumatol. 2009 Jun;36(6):1226-9. Epub 2009 May 15.PMID: 19447939 [PubMed - indexed for MEDLINE]Related articles
Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions.
Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M; Canadian Scleroderma Research Group.
J Rheumatol. 2009 Apr;36(4):768-72. Epub 2009 Feb 17.PMID: 19228662
Reports of abnormal cervical cancer screening tests in systemic sclerosis.
Bernatsky S, Hudson M, Pope J, Markland J, Robinson D, Jones N, Docherty P, Abu-Hakima M, Leclerc S, Dunne J, Smith CD, Sutton E, Khalidi N, Mathieu JP, Masetto A, Ligier S, Kaminska E, Baron M; Canadian Scleroderma Research Group.
Rheumatology (Oxford). 2009 Feb;48(2):149-51. Epub 2008 Dec 15. PMID: 19074957